Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Toshio SUWA"'
Autor:
Koji Chiba, Haiqing Dai, Susan Johnson, Toshio Suwa, Chieko Muto, John G. Teeter, Anne B. Cropp
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 50:505-509
OBJECTIVE To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of PF-00734200, a potent dipeptidyl peptidase-IV (DPP-IV) inhibitor, in Japanese subjects, and compare the results with those in Western subjects. MATERIALS AND ME
Publikováno v:
Drug Metabolism and Pharmacokinetics. 27:405-413
Cytochrome P450 2D6 (CYP2D6), which has a large number of genetic polymorphisms, is involved in the metabolism of a wide range of substrates. Dextromethorphan (DM) is a well-known probe drug for CYP2D6 and metabolic ratio (MR) is often used to measur
Publikováno v:
Drug Metabolism and Pharmacokinetics. 26:236-241
Tolterodine is known as a drug which exhibits ethnic differences in pharmacokinetics between Japanese and Koreans despite genetic similarities among the populations of East Asian countries. Tolterodine is mainly metabolized by CYP2D6 to a 5-hydroxyme
Publikováno v:
Journal of Antimicrobial Chemotherapy. 66:165-174
it is known that the efficacy of azithromycin, in animal infection models, is best correlated with AUC/MIC. The pharmacokinetic-pharmacodynamic (PK-PD) relationship for azithromycin, however, has not been previously confirmed with clinical data. The
Publikováno v:
The Journal of Clinical Pharmacology. 49:1071-1078
Linezolid (Zyvox), belonging to oxazolidinone antibiotics, is commonly used for the treatment of patients infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Although linezolid has been approved worldwide,
Publikováno v:
Drug Metabolism and Pharmacokinetics. 20:168-176
Summary: We previously established a method to predict the drug metabolism capacity of injured liver based on pharmacokinetic estimation of the amount of cytochrome P450 (CYP) in vivo (PKCYP test), by introducing the apparent liver-to-blood free conc
Autor:
Atsushi Furuya, O. Kasai, M. Sato, N. Kato, Masayuki Akimoto, Hiroyasu Ogata, S. Jingu, Toshio Suwa
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 28:191-199
The prediction performances of population pharmacokinetic-pharmacodynamic analysis of the two methods (a stepwise and a simultaneous estimations) were evaluated with respect to their accuracies and precisions. A study was designed to investigate the
Autor:
Akio Suzuki, Masayuki Akimoto, Izumi Iida, Takashi Ishizaki, Masayoshi Tani, Mitsuyo Hirota, Toshio Suwa, Shohei Higuchi, Kan Chiba
Publikováno v:
Drug Metabolism and Pharmacokinetics. 18:104-113
To clarify whether CYP2C19 is involved in the overall metabolism of clarithromycin (CAM) or not, in vitro studies using human liver microsomes and recombinant CYPs were performed by an approach based on the disappearance rate of parent compound from
Autor:
Hiroyasu Ogata, Shohei Higuchi, Atsushi Furuya, Masayuki Akimoto, J Gotoh, M Nozawa, Toshio Suwa, Shigeji Jingu
Publikováno v:
Journal of Pharmacy and Pharmacology. 54:921-927
A simultaneous analysis of the pharmacokinetics and pharmacodynamics of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, was made in dogs using a nonlinear mixed effect model. Plasma concentrations of T
Autor:
Shohei Higuchi, Masayuki Akimoto, Naokazu Nagahata, Kiyomi Fukushima, Toshio Suwa, Atsushi Furuya
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 49:99-102
Gastric pH levels were measured in samples of gastric aspirates from eight fasted beagle dogs. The gastric pH in fasting dogs fluctuated from 2.7 to 8.3, with a mean of 6.8±0.2 (SE). Each dog received the following four treatments in randomly-assign